Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RL | RIVN |
|---|---|---|
| Price | $362.32 | $14.80 |
| Change today | ▲ 2.04% | ▼ 0.94% |
| Market cap | $21.59B | $21.43B |
| Return, 3 months | -8.7% | -13.9% |
| Return, year to date | +3.3% | -24.9% |
| Return, 1 year | +15.4% | +1.3% |
| P/E (TTM) | 22.8 | -5.7 |
| P/B | 7.9 | 4.2 |
| P/E percentile vs own 5y | 67th | 9th |
| Dividend yield | 1.03% | – |
| Revenue growth (YoY, latest qtr) | +14.0% | +27.2% |
| Net profit growth (YoY) | +19.0% | +24.9% |
| Gross margin | 70.3% | 7.5% |
| Operating margin | 16.4% | -60.1% |
| Net margin | 11.8% | -55.0% |
| Return on equity | 37.5% | -57.9% |
| Analyst target vs. price | +25.9% | +26.7% |
| Analyst buy share | 100% | 42% |
| RSI (14) | 53 | 42 |
| 30-day volatility | 27.4% | 40.9% |
| Max drawdown, 1 year | -19.4% | -42.5% |
| Trend read | Mixed | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
